Stockreport

Eyenovia Announces Launch and Commercial Availability of Clobetasol Propionate Ophthalmic Suspension 0.05% for Post-Operative Inflammation and Pain Following Ocular Surgery

Eyenovia, Inc.  (EYEN) 
Last eyenovia, inc. earnings: 3/25 04:05 pm Check Earnings Report
PDF NEW YORK, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), an ophthalmic technology company, today announced the U.S. launch and commercial availabili [Read more]